Pharmacovigilance – News and Features

News
Semaglutide Helps Schizophrenia Patients Lose Weight Without Side Effects
In a 36-week study, semaglutide was found to aid in weight loss for people with schizophrenia without worsening psychotic symptoms. Participants lost nearly 14% of body weight, and there was an improvement in lean mass to fat mass ratio.

News
Could Sea Cucumbers Be Key to Stopping Cancer Spread?
Sea cucumbers are the ocean's janitors, cleaning the seabed and recycling nutrients back into the water. But this humble marine invertebrate could also hold the key to stopping the spread of cancer.

News
Common Antibiotic Could Provide a Template for New Blood Pressure Drugs
Scientists have discovered a surprising new role for a commonly used antibiotic that could open the door to a new family of improved therapies for high blood pressure and cardiovascular disease.

News
These Brain Circuits That Tell Us When to Eat – and When to Stop
Two new research papers have mapped out which pathways in the brain are responsible for driving hunger, food seeking and satiety. The findings could help to refine weight-loss drugs and reduce their side effects.

News
Next-Generation Weight Loss Drug Combines Elements of Four Hormones
Combining elements of four hormones into a single drug, researchers hope a next-generation weight loss drug will address not only obesity, but associated conditions like type 2 diabetes, cancer, and cardiovascular disease.

News
Once-Weekly Oral Risperidone Shows Promise in Schizophrenia Treatment
The STARLYNG-1 trial tested a weekly oral version of risperidone for schizophrenia, showing it maintains therapeutic drug levels and reduces side effects. The study found that the weekly pill may help improve medication adherence.

Article
Why Exercise Matters for Those Facing Cancer
This article examines how physical activity and exercise influence cancer prevention, mitigate treatment-related side effects, enhance quality of life and impact overall mortality in oncology patients.

News
GLP-1 Medications Produce Smaller Weight Loss in a Real-World Setting
Injectable GLP-1 drugs for obesity have been found to produce smaller weight loss in a real-world setting compared to randomized clinical trials because patients discontinue treatment or use lower maintenance dosages.

News
Creatine Benefits Extend Beyond Athletic Performance
Creatine, known for enhancing athletic performance, offers wide-ranging health benefits, including support for muscle mass and cognitive function. It’s especially useful for aging adults, athletes and vegetarians.

News
Energy Crisis Caused by Antibiotics Accelerates Resistance in E. coli
Antibiotics throw bacteria into an energy crisis that alters their metabolism and speeds up the evolution of antibiotic resistance.
Advertisement